Hansen et al. reported that semaglutide suppresses the recruitment of cytotoxic T-cells (CD8 + ) into hepatocytes in an animal model of non-alcoholic steatohepatitis (NASH) [54]. Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.